D 7717
Latest Information Update: 07 Apr 1999
At a glance
- Originator AstraZeneca
- Class Antiasthmatics; Antirheumatics
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 07 Apr 1999 Merger of Zeneca and Astra to form AstraZeneca completed